Resources

Neonatal Abstinence Syndrome Track: Class actions filed on behalf of children who will need life-long medical and other specialized care because of opioid-addicted pregnant moms

These cases seek to create a court-administered, continually-replenishing, dedicated no-limit nation-wide fund to provide for the short and long-term treatment of NAS affected infants who will require lifelong medical and therapeutic assistance. The financial responsibility for this fund is put on the prescription opioid manufacturers, distributors and retailers named in the suits rather than on cash-strapped government budgets and taxpayers.

—NAS MDL Updates—

Sept. 20 filing for separate NAS Baby MDL

Sept. 20 filing for separate NAS Baby MDL

Relative to:
Rees v. McKesson Corporation, et al.
S.D. IL, C.A. #18-00511; MDL Case #1:18-OP-45252
Wood v. Purdue Pharma L.P., et al
E.D. MO, C.A. #18-00385; MDL Case #1:18-OP-45264
Salmons v. Purdue Pharma L.P., et al
S.D. WV, C.A. #18-00385; MDL Case #1:18-OP-45268;
Ambrosio v. Purdue Pharma L.P., et al
C.D. CA, C.A. #18-02201; MDL Case #1:18-OP-45375
Flanagan v. Purdue Pharma L.P., et al
W.D. TN, C.A. #18-02194; MDL Case #1:18-OP-45405
Whitley, et al. v. Purdue Pharma L.P., et al
W.D. TN, C.A. #18-02290; MDL Case #1:18-OP-45598
Roach v. McKesson Corporation, et al.
E.D. LA, C.A. #18-04165; MDL Case No. #1:18-OP-45662
Hunt v. Purdue Pharma L.P., et al
D. MD, C.A. #18-01349; MDL Case No. #1:18-OP-45681

Motion: 
To establish a separate NAS Baby Track

Plaintiffs ask that the Court issue one or more Orders creating a separate discovery and litigation track for centralized discovery, case development, and bellwether trial(s) of Opioid Baby claims in this MDL. The relief requested requires modification of this Court=s CMO #1 in MDL 2804. It likely also requires a new Case Management Order governing the new track, which Plaintiffs are prepared to propose to the Court.

Suits filed: Sept. 20, 2018 before US Judicial Panel on MDL

Summary of Claims:
Actions taken by the Opioid Justice Team legal-medical-child advocacy partnership over the past month are calling into question exactly how best to craft a master settlement agreement within Multi-District Litigation now being negotiated by a federal judge in Cleveland, Ohio as it concerns the growing number of opioid-dependent newborns resulting from America’s synthetic drug crisis. The coalition of attorneys and medical experts advocating on behalf of opioid-dependent infants born and afflicted with Neonatal Abstinence Syndrome (NAS) petitioned this week to have a new and separate legal track or MDL created just for the long-term care of this special class of citizens.
Last month, a class action filed in Ohio on behalf of NAS babies asked to be removed from the current MDL. West Virginia attorneys filed a supporting brief to this action. In May, a request to include a NAS Baby track within the existing MDL was rejected by the federal Judge charged with control over the growing claims against opioid manufacturers and distributors. The argument advanced in this latest legal filing is that NAS babies and their caregivers will face a life-time of medical monitoring and specialized care because of opioid exposure in the womb. Medical experts Dr. Kanwaljeet S. Anand of Stanford University and Dr. Charles Werntz of West Virginia University argue that it is important to treat the NAS child as quickly as possible to promote the child’s long-term growth and development. Non-profits, like the organization Facing Addiction, agree.

Summary of Plaintiffs:
The previous class-actions filed in the MDL but rejected from a separate MDL track in May, 2018 by MDL Judge Polster.

Plaintiff/Lawyer/Media contact info:
Attorneys: Scott Bickford (504) 581-9065 or Celeste Brustowicz (504) 399-0009

Media published to date:
https://www.law360.com/classaction/articles/1084765?utm_source=rss&utm_medium=rss&utm_campaign=section

Filings:

NDOH – 895-4NDOH – 895-3NDOH 985-2NDOH 985-1Distributors OppositionManufacturer DefendantsProof of ServiceSchedule of ActionsStatement re Oral ArgumentNew MDL Needed for ‘Opioid BabiesExhibit 22- Neonatal Abstainance Monitoring Report (Werntz – 08.30.18)

August 30 Filing to Vacate MDL

August 30 Filing to Vacate MDL

Regarding: 
Cases consolidated in MDL regarding NAS Baby Classes, referencing Doyle v. Actavis LLC et al of Ohio

Petition to US Judicial Panel on MDL 

Filed: August 30, 2018

Summary of Claims: 
OJT attorneys representing class actions filed on behalf of babies who will need life-long medical and other specialized care because of opioid use by their pregnant moms are requesting U.S. District Court Judge Dan A. Polster remove such cases from inclusion in Multi-District Litigation. The filings represent at least 40 percent of all Neo-Natal Abstinence (NAS) or opioid-addicted babies born in the nation, according to Lead Counsel Scott Bickford, Suits are filed in states such as Louisiana, West Virginia, Illinois, California and Missouri. Earlier this summer, the Judge rejected legal petition for creation of a nationwide medical monitoring trust fund for NAS babies within the existing MDL litigation regarding prescription opioids.

Plaintiff/Lawyer/Media contact info:
Attorneys: Scott Bickford (504) 581-9065 or Celeste Brustowicz (504) 399-0009

 

Download Filing

—Filings—

CALIFORNIA

Ambrosio (CA Baby Class) Media Summary

Plaintiff Names
MELISSA AMBROSIO, INDIVIDUALLY AND AS NEXT FRIEND OF BABY G.A., and the Class: 
All California persons under the age of eighteen who were diagnosed with neonatal abstinence syndrome (NAS) and whose birth mother (1) used opioids during gestation and (2) had a medical prescription for opioids before or during the gestation period.

Defendant Names:
Purdue Pharma; McKesson Corp.; Cardinal Health; Amerisource Bergen; Teva Pharmaceuticals; Cephalon; Johnson & Johnson; Janssen Pharmaceuticals; Endo Pharmaceuticals, Inc.; Actavis Pharma; Watson Pharma (some defendants consolidated for clarity)

Suit filed: March 16, 2018 in US District Court, Central District of CA

Date transferred to MDL: 4/4/18

Summary of Claims: Seeking damages for the injuries, pain and suffering of thousands of CA children suffering NAS, funding for their future treatment and medical monitoring, and funding for ravaged California communities to build up the healthcare infrastructure necessary to deal with the crisis levels of infants born with NAS in this state.

Summary of Plaintiffs:  G.A.’s mother Melissa, formerly a surgical tech, had long been prescribed opioids to treat her fibromyalgia and autoimmune pancreatitis. This led to  withdrawal symptoms and addiction, and she eventually began methadone treatment. She continued to take methadone during her pregnancy with G.A. G.A. was born at Sutter Hospital on August 24, 2015 with opioids in her system and spent the next 7 week in the NICU, where she was weaned off opioids via morphine. She continues to suffer developmental delays, difficulty sleeping and eating, and goes to speech therapy 4 times a week.

Plaintiff-Lawyer contact info:
Celeste Brustowicz
Cooper Law Firm, LLC
Telephone: 504-399-0009
Email: cbrustowicz@sch-llc.com

Media ContactsPeter Mirijanian (202) 464-8803 or C. Brylski/D. Johnson (504) 897-6110

 

Download Filing

ILLINOIS

Rees (IL Baby Class) Media Summary

Plaintiff Names: Derric and Ceonda Rees (grandparents) obo Baby T.W.B. and the Class: All Illinois persons under the age of eighteen who were diagnosed with neonatal abstinence syndrome (NAS) and whose birth mother (1) used opioids during gestation and (2) had a medical prescription for opioids before or during the gestation period.Defendant Names: Purdue Pharma; McKesson Corp.; Cardinal Health; Amerisource Bergen; Teva Pharmaceuticals; Cephalon; Johnson & Johnson; Janssen Pharmaceuticals; Endo Pharmaceuticals, Inc.; Actavis Pharma; Watson Pharma (some defendants consolidated for clarity)

Suit filed: 2/28/18 in the Southern District of Illinois (18-00511)Date transferred to MDL: 3/14/18

Summary of Claims: Seeking damages for the injuries, pain and suffering of Illinois children suffering NAS, funding for their future treatment and medical monitoring, and funding for Illinois communities to build up the healthcare infrastructure necessary to deal with the crisis levels of infants born with NAS in Illinois.

Summary of Plaintiffs: Baby T.W.B.’s mother began her addiction when prescribed opiates as young teenager for a broken ankle and later for a broken hand. Her addiction to prescription opiates served as a gateway to a heroin addiction. T.W.B. was diagnosed with NAS at birth and and stayed in the NICU for a month. It is very difficult to soothe Baby T.W.B. and he is delayed in all areas of development. His grandparents Derec and Ceonda Rees are raising him. Ceonda is a nurse.

Plaintiff-Lawyer contact info:
Illinois counsel Sen. James Clayborne
618-239-0187 cell

St. Louis counsel Anthony Gray
314-385-9500

National counsel Celeste Brustowicz
The Cooper Law Firm, LLC
504-399-0009
cbrustowicz@sch-llc.com

Media ContactsPeter Mirijanian (202) 464-8803 or Cheron Brylski/Devin Johnson (504) 897-6110

Media published to date:
http://www.kfvs12.com/clip/14165644/class-action-lawsuit-filed-after-newborns-with-opioid-addictions

 

Download Filing

LOUISIANA

Roach (LA Baby Class) Media Summary

Plaintiff Names: Tyler Roach, on behalf of his child K.E.R. and the Class: All Louisiana persons under the age of eighteen who were diagnosed with neonatal abstinence syndrome (NAS) and whose birth mother (1) used opioids during gestation and (2) had a medical prescription for opioids before or during the gestation period.

Defendant Names:
An array of pharmaceutical manufacturers, distributors and retailers, all of whom netted millions if not billions of dollars due to unfair and deceptive trade practices that preyed on all Americans, including the unborn, say the attorneys.

Purdue Pharma; McKesson Corp.; Cardinal Health; Amerisource Bergen; Teva Pharmaceuticals; Cephalon; Johnson & Johnson; Janssen Pharmaceuticals; Endo Pharmaceuticals, Inc.; Actavis Pharma; Watson Pharma (some defendants consolidated for clarity)

Suit filed: Feb. 26, 2018 in 22nd Judicial District Court, Parish of St. Tammany, Louisiana

Date transferred to MDL: 5/22/18

Summary of Claims: Seeking damages for the injuries, pain and suffering of all children in Louisiana and U.S. suffering NAS, funding for their future treatment and medical monitoring, and funding for American communities to build up the healthcare infrastructure necessary to deal with the crisis levels of infants born with NAS in Louisiana and the other 49 states.

Summary of Plaintiffs: K.E.R.’s mother was injured in a car accident and was prescribed opioid pain killers as part of her treatment. She soon became addicted to the opioids she was prescribed. K.E.R.’s mother became pregnant with K.E.R. while addicted to opioids. She entered addiction treatment and was prescribed Suboxone, a replacement opioid.  K.E.R. was exposed in utero to the opioid his mother took during her pregnancy. When K.E.R. was born in 2014, he was jittery and wailed excessively. He was diagnosed with Neonatal Abstinence Syndrome and spent 11 days in the hospital.  K.E.R. did not speak until he was 2 years old and has behavioral issues. He is now under the care of his father Tyler Roach.

Plaintiff-Lawyer contact info:
Celeste Brustowicz
The Cooper Law Firm, LLC
504-566-1558
cbrustowicz@sch-llc.com

Jack Harang
504-810-4734

Media Contacts:
Peter Mirijanian (202) 464-8803 or C. Brylski/D. Johnson (504) 897-6110

Media published to date (sampling):
http://www.theadvocate.com/baton_rouge/news/article_a157bb42-4d9a-11e8-b271-03082af75e27.html
http://www.brylskicompany.com/press-releases/first-lawsuit-in-nation-to-protect-children-of-opioid-addicted-parents-filed
https://www.huffingtonpost.com/entry/opioids-lawsuit-louisiana_us_5a96ee65e4b0e6a5230438d2
https://www.bna.com/opioid-drugmakers-distributors-n57982090228/
http://uptownmessenger.com/2018/03/danae-columbus-opioid-epidemic-is-evident-everywhere-even-the-car-wash/

 

Download Filing

MARYLAND

Hunt (MD Baby Class) Media Summary

Plaintiff Names:
Shannon Hunt (aunt) obo Baby S.J. and the Class: All Maryland persons under the age of eighteen who were diagnosed with neonatal abstinence syndrome (NAS) and whose birth mother (1) used opioids during gestation and (2) had a medical prescription for opioids before or during the gestation period.Defendant Names:
Purdue Pharma; McKesson Corp.; Cardinal Health; Amerisource Bergen; Teva Pharmaceuticals; Cephalon; Johnson & Johnson; Janssen Pharmaceuticals; Endo Pharmaceuticals, Inc.; Actavis Pharma; Watson Pharma (some defendants consolidated for clarity)

Suit filed: May 10, 2018 in U.S. District Court of Maryland

Date transferred to MDL: 5/30/18

Summary of Claims: Seeking damages for the injuries, pain and suffering of Maryland and U.S. children suffering NAS, funding for their future treatment and medical monitoring, and funding for MD and U.S. communities to build up the healthcare infrastructure necessary to deal with the crisis levels of infants born with NAS in Maryland and the other 49 states and all U.S. territories.

Summary of Plaintiffs: Baby S.J. was born to an opioid addicted mother and spent the next 7 weeks in the NICU at John Hopkins Bayview. She is now 10 years old and in the care of her aunt Shannon Hunt.

Plaintiff-Lawyer contact info:
Celeste Brustowicz

COOPER LAW FIRM, LLC
Telephone: 504-399-0009
Email: cbrustowicz@sch-llc.com
Media Contacts:
Peter Mirijanian (202) 464-8803 or C. Brylski/D. Johnson (504) 897-6110Media published to date:
http://www.brylskicompany.com/press-releases/medical-legal-teams-move-to-protect-and-help-opioid-affected-infants-and-children-in-eight-states

 

Download filing

MISSOURI

Wood (MO Baby Class) Media Summary

Plaintiff Names: Rachel Wood (adoptive mother and biological aunt) obo Baby O.W. and the Class: All Missouri persons under the age of eighteen who were diagnosed with neonatal abstinence syndrome (NAS) and whose birth mother (1) used opioids during gestation and (2) had a medical prescription for opioids before or during the gestation period.

Defendant Names: Purdue Pharma; McKesson Corp.; Cardinal Health; Amerisource Bergen; Teva Pharmaceuticals; Cephalon; Johnson & Johnson; Janssen Pharmaceuticals; Endo Pharmaceuticals, Inc.; Actavis Pharma; Watson Pharma (some defendants consolidated for clarity)

Suit filed: 3/3/18 in the US District Court of Missouri Eastern District (18-00352)

Date transferred to MDL: 3/20/18

Summary of Claims: Seeking damages for the injuries, pain and suffering of Missouri children suffering NAS, funding for their future treatment and medical monitoring, and funding for Missouri communities to build up the healthcare infrastructure necessary to deal with the crisis levels of infants born with NAS in Missouri.

Summary of Plaintiffs: Baby O.W. was born addicted to opioids on April 6, 2015 at Poplar Bluff Regional Medical Center and heli-transferred to the NICU at St. Francis Medical Center in Cape Girardeau where she spent the first 20 days of her life. Her father’s sister, Rachel Wood, came to the hospital to help O.W. and realized she needed to bring her home to give O.W. the care she needed. O.W.’s parents, still suffering from opioid addiction, quickly signed over their parental rights and Rachel formally adopted her O.W., now 3 years old, is very small for her age and has serious behavioral problems and mood swings, and requires frequently counseling which will need to continue into adulthood.

Plaintiff/Lawyer Contact Info:
Missouri counsel Anthony Gray (314-385-9500)

National counsel Celeste Brustowicz
The Cooper Law Firm, LLC
504-399-0009
cbrustowicz@sch-llc.com

Media ContactsPeter Mirijanian (202) 464-8803 or Cheron Brylski/Devin Johnson (504) 897-6110

 

Download Filing

NEW YORK

NAS: NY Niagara County

Plaintiff Names: Guardian AMH and Baby C.E.

Defendant Names: An array of prescription drug manufacturers, distributors and sellers that have advanced the U.S.’ growing opioid addiction epidemic, including Walgreens, Purdue Pharma, and Johnson & Johnson

Suits filed: August 23, 2018 in Niagara County Supreme Court, New York

Date transferred to MDL: 3/20/18

Summary of Claims: Newborn babies are the most vulnerable citizens in the opioid problems sweeping our nation; their lives and developmental potential are disrupted by Neonatal Abstinence Syndrome (NAS), but arrangements for their short-term and long-term care have been ignored.

Summary of Plaintiffs: The plaintiff in the case is a Niagara County guardian for Baby C.E., a child born 13 months ago with severe withdrawal symptoms that have caused permanent developmental issues for the child due to the opioid use of the parent. The baby’s doctors predict Baby C.E. will require years of treatment and counseling, at untold expense. Baby C.E.’s mother was prescribed opioids before pregnancy, became addicted and later turned to heroin.

Baby C.E. is representative of the 8.5 per 1000 Neonatal Abstinence Syndrome (NAS) babies born to pregnant women who used opioids in New York State…and incidence that has grown from 1.9 per 1000 births in the last 10 years according to the New York State Department of Health. Moreover, out of every five Medicaid-served mothers consumed opioids at some point during their pregnancy resulting in addicted babies, according to the medical-legal team seeking to treat and protect the opioid dependent babies, children and youth.

 

Plaintiff/Lawyer Contact Info:
Attorney Don Creadore (212) 355-7200 

Media ContactsPeter Mirijanian (202) 464-8803 or Cheron Brylski/Devin Johnson (504) 897-6110

 

Download Filing

OHIO

Doyle (OH Baby Class) Media Summary

Plaintiff Names:
Erin Doyle obo Baby D.F. and the Class: All Ohio persons under the age of eighteen who were diagnosed with neonatal abstinence syndrome (NAS) and whose birth mother (1) used opioids during gestation and (2) had a medical prescription for opioids before or during the gestation period.Defendant Names:
Named as defendants in the suit are an array of pharmaceutical manufacturers, distributors and retailers, all of whom netted millions if not billions of dollars due to unfair and deceptive trade practices that preyed on all Americans, including the unborn.

Purdue Pharma; McKesson Corp.; Cardinal Health; Amerisource Bergen; Teva Pharmaceuticals; Cephalon; Johnson & Johnson; Janssen Pharmaceuticals; Endo Pharmaceuticals, Inc.; Actavis Pharma; Watson Pharma (some defendants consolidated for clarity)

Suit filed: May 9, 2018 in Ross County, Ohio Common Pleas Court

Date transferred to MDL: Not transferred yet.

Summary of Claims: Seeking damages for the injuries, pain and suffering of thousands of Ohio children suffering NAS, funding for their future treatment and medical monitoring, and funding for Ohio communities to build up the healthcare infrastructure necessary to deal with the crisis levels of infants born with NAS in this state.

Plaintiff Summary:
Born 9/5/17 Mother 33 years old. Had right eye melanoma resulting in removal of eye and prosthesis placement.  Subsequent opioid drug abuse related to the eye problem.

Late with prenatal care and on Suboxone during pregnancy. Baby born positive for buprenorphine (synthetic opioid). Physicians concerned about withdrawal symptoms for baby and he was placed on appropriate protocol for same.

Plaintiff-Lawyer contact info:
Anna Villarreal (local counsel)
740-772-4466 (office)
anna@avlawohio.comCeleste Brustowicz (national counsel)

The Cooper Law Firm, LLC
504-399-0009 (office)
cbrustowicz@sch-llc.com
Media Contacts:
Peter Mirijanian (202) 464-8803 or C. Brylski/D. Johnson (504) 897-6110

Media published to date:
http://www.brylskicompany.com/press-releases/medical-legal-team-moves-to-protect-and-help-opioid-affected-infants-and-children-in-ohio

 

Download Filing

TENNESSEE | Flanagan

Flanagan (TN Fed Baby Class) Media Summary

Plaintiff Names:
DARREN AND ELENA FLANAGAN,
INDIVIDUALLY AND AS ADOPTIVE PARENTS

AND NEXT FRIENDS OF BABY K.L.F., and the Class: All Tennessee persons under the age of eighteen who were diagnosed with neonatal abstinence syndrome (NAS) and whose birth mother (1) used opioids during gestation and (2) had a medical prescription for opioids before or during the gestation period.

Defendant Names:
Purdue Pharma; McKesson Corp.; Cardinal Health; Amerisource Bergen; Teva Pharmaceuticals; Cephalon; Johnson & Johnson; Janssen Pharmaceuticals; Endo Pharmaceuticals, Inc.; Actavis Pharma; Watson Pharma (some defendants consolidated for clarity)

Suit filed: March 21, 2018 in the USDC Western District of Tennessee (Western Div.)

Date transferred to MDL: 4/10/18

Summary of Claims: Seeking damages for the injuries, pain and suffering of thousands of Tennessee and U.S. children suffering NAS, funding for their future treatment and medical monitoring, and funding for Tennessee and U.S. communities to build up the healthcare infrastructure necessary to deal with the crisis levels of infants born with NAS in this state and all others in the U.S..

Plaintiff-Lawyer contact info:
MeLisa J. Williams (local attorney and former nurse)
16980 Hwy 64, Suite A
P.O. Box 515
Somerville, TN 38068
901-465-2622 (phone)
901-813-8336 (fax)
Email: mjw@mjwilliamslaw.com

Jack Harang (national counsel)
504-810-4734
jwharang@gmail.com

Media Contacts:
Peter Mirijanian (202) 464-8803 or C. Brylski/D. Johnson (504) 897-6110

Media published to date:
http://www.brylskicompany.com/press-releases/medical-legal-teams-move-to-protect-and-help-opioid-affected-infants-and-children-in-eight-states
https://www.bna.com/opioid-drugmakers-distributors-n57982090228/

 

Download filing

TENNESSEE | Whitley

Whitley (TN State Ct Baby Class) Media Summary

Plaintiff Names:
Rev. James Holland and Teri Holland obo Baby ACH [available for interviews]
Roxie Whitley and Baby ZBD
Chris and Diane Denson and Baby LDL
The Class: All Tennessee persons under the age of eighteen who were diagnosed with neonatal abstinence syndrome (NAS) and whose birth mother (1) used opioids during gestation and (2) had a medical prescription for opioids before or during the gestation period.Defendant Names:
Purdue Pharma; McKesson Corp.; Cardinal Health; Amerisource Bergen; Teva Pharmaceuticals; Cephalon; Johnson & Johnson; Janssen Pharmaceuticals; Endo Pharmaceuticals, Inc.; Actavis Pharma; Watson Pharma; Fred’s Stores of Tennessee, Inc. (some defendants consolidated for clarity)

Suit filed: March 28, 2018 in 25th Judicial District of Fayette County, Tennessee at Somerville

Date transferred to MDL: 5/22/18

Summary of Claims: Seeking damages for the injuries, pain and suffering of thousands of Tennessee children suffering NAS, funding for their future treatment and medical monitoring, and funding for TN communities to build up the healthcare infrastructure necessary to deal with the crisis levels of infants born with NAS in this state.

Plaintiff Summary:  Jim is the loving adopted father of a young girl born addicted to opioids, and the pastor of St. Patrick Presbyterian in Collierville, TN near Memphis. He is named class representative in a class action filed on behalf of TN children suffering Neonatal Abstinence Syndrome.

Plaintiff-Lawyer contact info:
MeLisa J. Williams (local attorney and former nurse)
901-465-2622
mjw@mjwilliamslaw.com

Jack Harang (national counsel)
504-810-4734
jwharang@gmail.com

Media Contacts:
Peter Mirijanian (202) 464-8803 or Cheron Brylski/Devin Johnson (504) 897-6110

Media published to date:
http://www.brylskicompany.com/press-releases/medical-legal-teams-move-to-protect-and-help-opioid-affected-infants-and-children-in-eight-states

 

Download Filing

WEST VIRGINIA

Salmons (WV Baby Class) Media Summary

Plaintiff Names:
WALTER AND VIRGINIA SALMONS, INDIVIDUALLY AND AS THE NEXT FRIEND OR GUARDIAN OF MINOR W.D.
The Class: All persons in the U.S. under the age of eighteen who were diagnosed with neonatal abstinence syndrome (NAS) and whose birth mother (1) used opioids during gestation and (2) had a medical prescription for opioids before or during the gestation period.
Defendant Names:Purdue Pharma; McKesson Corp.; Cardinal Health; Amerisource Bergen; Teva Pharmaceuticals; Cephalon; Johnson & Johnson; Janssen Pharmaceuticals; Endo Pharmaceuticals, Inc.; Actavis Pharma; Watson Pharma (some defendants consolidated for clarity)

Suit filed: March 2, 2018 in U.S. District Court, Southern District West Virginia at CharlestonDate transferred to MDL: 3/20/18Summary of Claims: Seeking damages for the injuries, pain and suffering of thousands of West Virginia children suffering NAS, funding for their future treatment and medical monitoring, and funding for WVa communities to build up the healthcare infrastructure necessary to deal with the crisis levels of infants born with NAS in this state.

Plaintiff-Lawyer contact info:
Kevin W. Thompson (local and national counsel)
Thompson Barney Law Firm
2030 Kanawha Boulevard, East
Charleston, West Virginia 25311
Telephone: (304) 343-4401
kwthompsonwv@gmail.com

Susan J. Vanzant, Esquire (local counsel)
Post Office Box 987
Williamson, West Virginia 25661
Telephone: (304) 235-4540

 

Download filing

The worst part of America’s growing opioid addiction epidemic is the unintended victims: Men and women who became unwitting users because they were simply following their doctor’s orders on use of prescribed medications. Here are some articles compiled by our medical experts which explore the statistical scope of this crisis.

Recent press coverage of NAS Baby filings

Lawyers for Opioid-Addicted Babies Push For Seperate Legal Proceedings
Bloomberg Law

Open Article

Opioids’ Most Innocent Victims
Cleveland.com

Open Article

Attys Relaunch Bid For ‘Opioid Babies’ Track In MDL
Law 360

Open Article

In the Opioid Litigation, Who Represents Addicted Babies
The National Journal

Open Article

New MDL Needed for ‘Opioid Babies,’ Attys Say
Law 360

Open Article

 

OPIOID OVERDOSE COUNTS

Overdose Deaths Involving Opioids Coca
Centers for Disease Control and Prevention

Open Article

Provisional Counts of Drug Overdose Deaths
National Center for DHealth Statistics

Open Article

Teratogenic effects of opioids
Pediatrics  |  June 2017, VOLUME 139 / ISSUE 6

Open Article

JPML Info and Ruling for Nov. 29, 2018

Open ArticleWESTLAW DOCUMENT: JPMLInfants Born Opioid-Dependent Products Liability Litigation

Lessons from Tobacco regarding Opioid MDL

Open Article

Opioid Use Disorder Documented at Delivery Hospitalization
Centers for Disease Control and Prevention

Open Article

Consequences of prenatal opioid use for newborns
ACTA PÆDIATRICA

Open Article

Long-Acting Opioids for Treating Neonatal Abstinence Syndrome
Jama Network

Open Article

Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants
Centers for Disease Control and Prevention

Open Article

CDC Public Health Grand Rounds
Centers for Disease Control and Prevention

Open Presentation

Medical Facts: Opioid Use Disorder in Pregnancy (OUDP) and Neonatal Abstinence Syndrome (NAS) in their offspring

Open facts

Rooming-In to Treat Neonatal Abstinence Syndrome: Improved Family-Centered Care at Lower Cost
Pediatrics: Volume 137

Open Article

NAS Baby Legal-Medical Team Approach
National Institute on Drug Abuse

Download Powerpoint Presentation

Newborns in opioid withdrawal may do better on methadone than morphine, major study finds
The Inquirer philly.com

Read Article

What Is The Difference Between Methadone And Oxycodone?
drugrehab.org

Read Article